Sustainability in Pharmaceuticals Industry Ethical Pricing in the Pharmaceutical Industry

The reality of medicine if the modern era is that resources must be allocated to help support the development of new pharmaceutical and in turn, there must also be a way to compensate those who devote their resources to help cure some of the preventable diseases that plague the modern age. The moral issue at stake here is distributive justice, and Rawls' framework is especially germane since it underlines the material benefits everyone deserves as Kantian persons and the need for an egalitarian approach for the distribution of society's essential commodities such as health care; the concern for distributive justice should be a critical factor in the equation of variables used to set prices for pharmaceuticals (Spinello, 1992).

For example, the question of how humanity delivers on a social scale that advances that humanity makes is among one of the essential questions in framing what a sustainable future might look like. There are also pragmatic considerations that must be made. For example, how should intellectual properties be weighed in instances where the protection of intellectual capital will almost certainly result in human lives. Such questions address the complexities that exist in the compensation structures for modern healthcare innovations and these questions are far from having clear answers. This analysis will try to identify some of the core considerations...

The stakeholder set is wide and diverse and consists of investors who are interested in their personal gains, as well as patients (stakeholders) who are interested in their physical, or mental, well-being. Balancing the different goals of different sets of stakeholders represents a tactical, but also moral, dilemma in many circumstances. For example, it is likely that the level of innovation would be somewhat stifled if there wasn't the potential of massive rewards, but at the same time, what are the obligations to society in general. There are obviously trade-offs at every point in the possible spectrum of risk, reward, and the public good.
John Rawls who proposes that all economic goods and services should be distributed roughly equally except for in the cases in which unequal distribution works to advantage the entire society as well. For example, some level of inequality could in fact play a motivating role in leading individuals towards hard work and innovation. Furthermore, Rawls argues from a Kantian position and diverges from other egalitarian theories by making provision for inequality when they enhance the position of the least advantaged members of society.…